NCT00041106 2013-06-05
Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
1 trialsMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter × Gefitinib × Genitourinary × Clear all